AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ELI LILLY & Co Director's Dealing 2026

Jan 15, 2026

29745_dirs_2026-01-15_54ff2cc5-1103-4e64-86db-7ff24830373f.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Aktis Oncology, Inc. (AKTS)
CIK: 0002035832
Period of Report: 2026-01-12

Reporting Person: ELI LILLY & Co (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6344114	Direct